Skip to content
Activity vs Effectiveness: What FDA Really Wants to See episode artwork

Mar 29, 2026 10 min

Activity vs Effectiveness: What FDA Really Wants to See

from The GMP Insider

In Quality Assurance, activity is often mistaken for effectiveness. CAPAs are closed, training is completed, and SOPs are revised — but the underlying system may still remain weak. In this episode of The GMP Insider, we explore why FDA inspections focus not only on whether actions were taken, but on whether those actions actually improved control and reduced risk. Discussion topics include: • The difference between completing actions and achieving effectiveness • Why CAPA closure does not always mean recurrence was prevented • The limitations of common quality metrics • How FDA evaluates risk reduction and process improvement • Why stronger systems require more than box-checking Quality is not measured by how much activity happened. It is measured by whether the risk went down.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Activity vs Effectiveness: What FDA Really Wants to See

0:00 10:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The GMP Insider?

This episode is 10 minutes long.

When was this The GMP Insider episode published?

This episode was published on March 29, 2026.

Can I download this The GMP Insider episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.